Funding for this research was provided by:
National Natural Science Foundation of China (81871711)
National Key Research and Development Program of China Stem Cell and Translational Research (2018YFC0910202)
Received: 3 December 2020
Revised: 25 January 2021
Accepted: 3 February 2021
First Online: 17 February 2021
Ethics approval and consent to participate
: This study was approved by the Clinical Research Ethics Committee of Sun Yat-sen University Cancer Center and Henan Tumor Hospital, and all patients provided written informed consent at the first visit to our center.
: Not applicable.
: The authors declare that they have no competing interests.